Absorption |
Blood-Brain Barrier | BBB- | 0.9284 |
Human Intestinal Absorption | HIA- | 0.5845 |
Caco-2 Permeability | Caco2- | 0.7585 |
P-glycoprotein Substrate | Substrate | 0.7503 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8116 |
Non-inhibitor | 0.7401 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9266 |
Distribution |
Subcellular localization | Nucleus | 0.4879 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7343 |
CYP450 2D6 Substrate | Non-substrate | 0.8420 |
CYP450 3A4 Substrate | Substrate | 0.5107 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8503 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8856 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5157 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5232 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9385 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9345 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9848 |
Non-inhibitor | 0.7725 |
AMES Toxicity | Non AMES toxic | 0.8283 |
Carcinogens | Non-carcinogens | 0.9004 |
Fish Toxicity | High FHMT | 0.9725 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9817 |
Honey Bee Toxicity | Low HBT | 0.8017 |
Biodegradation | Not ready biodegradable | 0.9883 |
Acute Oral Toxicity | III | 0.7080 |
Carcinogenicity (Three-class) | Non-required | 0.7158 |